HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.

AbstractOBJECTIVE:
To explore the monetary value of rheumatoid arthritis related loss of productivity in patients with early active disease.
METHODS:
In a prospective cohort substudy of the FIN-RACo Trial, 162 patients with recent onset rheumatoid arthritis, aged 18 to 65 years and available to the workforce, were followed up for five years. Loss of work productivity in euros 2002 was estimated by data on absence for sickness and on income (human capital approach) from official databases. Treatment responses were evaluated by area under the curve (AUC) of the ACR-N measure and by increase in number of erosions in radiographs of hands and feet. The health assessment questionnaire (HAQ) at six months was linked to the International Classification of Functioning, Disability and Health (ICF).
RESULTS:
In all, 120 (75%) patients, women more often (82%) than men (61%) (p=0.002), lost work days. The mean lost productivity per patient-year was euro7217 (95% confidence interval (CI), 5561 to 9148): for women, euro6477 (4858 to 8536) and for men, euro8443 (5389 to 12,898). There was an inverse correlation with improvement: euro1101 (323 to 2156) and euro14 952 (10,662 to 19,852) for the highest and lowest quartiles of AUC of ARC-N, respectively. Lost productivity was associated with increase in the number of erosions and with disability in "changing and maintaining body position" subcategory of the ICF.
CONCLUSIONS:
Despite remission targeted treatment with disease modifying antirheumatic drugs, early rheumatoid arthritis results in substantial loss of productivity. A good improvement in the disease reduces the loss markedly.
AuthorsK Puolakka, H Kautiainen, M Pekurinen, T Möttönen, P Hannonen, M Korpela, M Hakala, M Arkela-Kautiainen, R Luukkainen, M Leirisalo-Repo, FIN-RACo Trial Group
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 65 Issue 7 Pg. 899-904 (Jul 2006) ISSN: 0003-4967 [Print] England
PMID16291811 (Publication Type: Journal Article)
Chemical References
  • Antirheumatic Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Antirheumatic Agents (therapeutic use)
  • Area Under Curve
  • Arthritis, Rheumatoid (drug therapy, economics, pathology)
  • Cost of Illness
  • Finland
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Prospective Studies
  • Remission Induction
  • Sex Distribution
  • Sickness Impact Profile
  • Work Schedule Tolerance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: